Press release

“There is a lot of very interesting communication work happening long before a product enters its commercial phase,” says Alan Emmins, a Founding Partner at &Robin. “Bringing more scientific capabilities into the &Robin offer not only increases our expertise, it will further drive the quality of our existing launch readiness and campaign work.”

&Robin’s Scientific Engagement team will partner with KOLs and PAGs to support market shaping and ensure that scientific storytelling is optimised for key stakeholder communities: overcoming barriers, informing clinical decision making and maximising opportunities.

“We always knew this was where we wanted &Robin to be,” says Kristian Holden, Senior Partner at &Robin. “Working with a deeper understanding of unmet needs and therapy areas, partnering with complex ecosystem of stakeholders, and contextualising science for specific audiences. We’re excited to combine the scientific expertise of the London team with the with the strong Scandinavian design aesthetic of Copenhagen.”

Terry Bradley, Scientific Engagement Director and Partner at &Robin, has previously developed international med comms teams and managed leading medical education agencies in London, including Ogilvy, Pollen, Health Unlimited and WE. Terry has worked with the world’s leading pharmaceutical companies, as well as biotech companies looking to commercialise their innovations.

Karen Lipworth, Director of Medical Writing at &Robin, brings many years of scientific storytelling experience, messaging and narrative development, and in-depth clinical trial communications support.

“This is a very timely opportunity for both teams”, says Terry Bradley. “We are seeing a great deal of change in terms of what our pharma clients need from their med comms partners. Agencies that couple deep scientific expertise with meaningful stakeholder engagement and education, who can meet the communications needs throughout the entire launch journey, will become true client partners.”

With more healthcare companies than ever looking to commercialise their innovations, it’s the hearts and minds of healthcare practitioners, KOLs, decision makers and patients that are now in play. &Robin is perfectly positioned to bring more communication-centred design and thoughtful creativity to the highly scientific, med comms space. With a combination of strategic, creative and scientific services, &Robin helps its clients develop long-term, meaningful relationships that drive positive change.

For more information visit androbin.co.uk, or email Terry Bradley at: terry@androbin.co.uk or Alan Emmins at: alan@androbin.dk